Jundishapur Journal of Chronic Disease Care

Published by: Kowsar

Overlapping of Asthma and Chronic Obstructive Pulmonary Disease: A Literature Review

Fatemeh Jafari Pour 1 , Tahereh Toulabi 2 , 3 , * , Halimeh Khatoon Zare Elmi 1 , Hadis Koganinejad 1 and Leila Jafaripour 4 , 5
Authors Information
1 Student Research Committee, School of Nursing and Midwifery, Lorestan University of Medical Sciences, Khorramabad, Iran
2 Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
3 Department of Nursing, School of Nursing and Midwifery, Lorestan University of Medical Sciences, Khorramabad, Iran
4 Department of Anatomy, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran
5 Department of Anatomical Science, Afzalipour Medical School, Kerman University of Medical Sciences, Kerman, Iran
Article information
  • Jundishapur Journal of Chronic Disease Care: 7 (4); e83401
  • Published Online: December 29, 2018
  • Article Type: Review Article
  • Received: August 17, 2018
  • Revised: November 27, 2018
  • Accepted: December 20, 2018
  • DOI: 10.5812/jjcdc.83401

To Cite: Jafari Pour F, Toulabi T, Zare Elmi H K, Koganinejad H, Jafaripour L. Overlapping of Asthma and Chronic Obstructive Pulmonary Disease: A Literature Review, Jundishapur J Chronic Dis Care. Online ahead of Print ; 7(4):e83401. doi: 10.5812/jjcdc.83401.

Abstract
Copyright © 2018, Jundishapur Journal of Chronic Disease Care. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
Footnotes
References
  • 1. Geneva Infant Feeding Association. The global strategy for asthma management and prevention. Geneva: Geneva Infant Feeding Association; 2014.
  • 2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease; 2014.
  • 3. Nakawah MO, Hawkins C, Barbandi F. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. J Am Board Fam Med. 2013;26(4):470-7. doi: 10.3122/jabfm.2013.04.120256. [PubMed: 23833163].
  • 4. Barnes PJ. Asthma-COPD Overlap. Chest. 2016;149(1):7-8. doi: 10.1016/j.chest.2015.08.017. [PubMed: 26757281].
  • 5. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: What are its features and how important is it? Thorax. 2009;64(8):728-35. doi: 10.1136/thx.2008.108027. [PubMed: 19638566].
  • 6. Global Initiative for Chronic Obstructive Lung Disease. Diagnosis of diseases of chronic airflow limitation: Asthma COPD and asthma-COPD overlap syndrome (ACOS) based on the global strategy for asthma management and prevention and the global strategy for the diagnosis, management and prevention og COPD. Global Initiative for Chronic Obstructive Lung Disease; 2014. 15 p.
  • 7. Milanese M, Di Marco F, Corsico AG, Rolla G, Sposato B, Chieco-Bianchi F, et al. Asthma control in elderly asthmatics. An Italian observational study. Respir Med. 2014;108(8):1091-9. doi: 10.1016/j.rmed.2014.05.016. [PubMed: 24958604].
  • 8. Bateman ED, Reddel HK, van Zyl-Smit RN, Agusti A. The asthma-COPD overlap syndrome: Towards a revised taxonomy of chronic airways diseases? Lancet Respir Med. 2015;3(9):719-28. doi: 10.1016/S2213-2600(15)00254-4. [PubMed: 26255108].
  • 9. Miravitlles M, Alcazar B, Alvarez FJ, Bazus T, Calle M, Casanova C, et al. What pulmonologists think about the asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2015;10:1321-30. doi: 10.2147/COPD.S88667. [PubMed: 26270415]. [PubMed Central: PMC4507793].
  • 10. Andersen H, Lampela P, Nevanlinna A, Saynajakangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J. 2013;7(4):342-6. doi: 10.1111/crj.12013. [PubMed: 23362945].
  • 11. Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): Opportunities and challenges. Curr Opin Pulm Med. 2015;21(1):74-9. doi: 10.1097/MCP.0000000000000118. [PubMed: 25405671].
  • 12. Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpelainen M, Kinnula VL, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48(3):279-85. doi: 10.3109/02770903.2011.555576. [PubMed: 21323613].
  • 13. Louie S, Zeki AA, Schivo M, Chan AL, Yoneda KY, Avdalovic M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: Pharmacotherapeutic considerations. Expert Rev Clin Pharmacol. 2013;6(2):197-219. doi: 10.1586/ecp.13.2. [PubMed: 23473596].
  • 14. Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The asthma-COPD overlap syndrome: A common clinical problem in the elderly. J Allergy (Cairo). 2011;2011:861926. doi: 10.1155/2011/861926. [PubMed: 22121384]. [PubMed Central: PMC3205664].
  • 15. Kumbhare S, Pleasants R, Ohar JA, Strange C. Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the United States. Ann Am Thorac Soc. 2016;13(6):803-10. doi: 10.1513/AnnalsATS.201508-554OC. [PubMed: 26974689].
  • 16. van Boven JF, Roman-Rodriguez M, Palmer JF, Toledo-Pons N, Cosio BG, Soriano JB. Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life. Chest. 2016;149(4):1011-20. doi: 10.1016/j.chest.2015.12.002. [PubMed: 26836892].
  • 17. Sorino C, Pedone C, Scichilone N. Fifteen-year mortality of patients with asthma-COPD overlap syndrome. Eur J Intern Med. 2016;34:72-7. doi: 10.1016/j.ejim.2016.06.020. [PubMed: 27357368].
  • 18. Kurashima K, Takaku Y, Ohta C, Takayanagi N, Yanagisawa T, Sugita Y. COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:479-87. doi: 10.2147/COPD.S97343. [PubMed: 27019598]. [PubMed Central: PMC4786066].
  • 19. Brzostek D, Kokot M. Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological study. Postepy Dermatol Alergol. 2014;31(6):372-9. doi: 10.5114/pdia.2014.47120. [PubMed: 25610352]. [PubMed Central: PMC4293393].
  • 20. Chung JW, Kong KA, Lee JH, Lee SJ, Ryu YJ, Chang JH. Characteristics and self-rated health of overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2014;9:795-804. doi: 10.2147/COPD.S61093. [PubMed: 25092973]. [PubMed Central: PMC4113567].
  • 21. Izquierdo-Alonso JL, Rodriguez-Gonzalezmoro JM, de Lucas-Ramos P, Unzueta I, Ribera X, Anton E, et al. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). Respir Med. 2013;107(5):724-31. doi: 10.1016/j.rmed.2013.01.001. [PubMed: 23419828].
  • 22. de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): Prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8(5). e62985. doi: 10.1371/journal.pone.0062985. [PubMed: 23675448]. [PubMed Central: PMC3651288].
  • 23. Lee HY, Kang JY, Yoon HK, Lee SY, Kwon SS, Kim YK, et al. Clinical characteristics of asthma combined with COPD feature. Yonsei Med J. 2014;55(4):980-6. doi: 10.3349/ymj.2014.55.4.980. [PubMed: 24954327]. [PubMed Central: PMC4075403].
  • 24. Menezes AMB, Montes de Oca M, Perez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297-304. doi: 10.1378/chest.13-0622. [PubMed: 24114498].
  • 25. Pleasants RA, Ohar JA, Croft JB, Liu Y, Kraft M, Mannino DM, et al. Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. COPD. 2014;11(3):256-66. doi: 10.3109/15412555.2013.840571. [PubMed: 24152212].
  • 26. Miravitlles M, Soriano JB, Ancochea J, Munoz L, Duran-Tauleria E, Sanchez G, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107(7):1053-60. doi: 10.1016/j.rmed.2013.03.007. [PubMed: 23597591].
  • 27. Papaiwannou A, Zarogoulidis P, Porpodis K, Spyratos D, Kioumis I, Pitsiou G, et al. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): Current literature review. J Thorac Dis. 2014;6 Suppl 1:S146-51. doi: 10.3978/j.issn.2072-1439.2014.03.04. [PubMed: 24672688]. [PubMed Central: PMC3966158].
  • 28. Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol. 2014;50 Suppl 1:1-16. doi: 10.1016/S0300-2896(14)70070-5. [PubMed: 24507959].
  • 29. Soler-Cataluna JJ, Cosio B, Izquierdo JL, Lopez-Campos JL, Marin JM, Aguero R, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48(9):331-7. doi: 10.1016/j.arbres.2011.12.009. [PubMed: 22341911].
  • 30. Koblizek V, Chlumsky J, Zindr V, Neumannova K, Zatloukal J, Zak J, et al. Chronic obstructive pulmonary disease: Official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157(2):189-201. doi: 10.5507/bp.2013.039. [PubMed: 23733084].
  • 31. Kankaanranta H, Harju T, Kilpelainen M, Mazur W, Lehto JT, Katajisto M, et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: The finnish guidelines. Basic Clin Pharmacol Toxicol. 2015;116(4):291-307. doi: 10.1111/bcpt.12366. [PubMed: 25515181]. [PubMed Central: PMC4409821].
  • 32. GINA-GOLD. Diagnosis of disease of chronic airflow limitation: Asthma, (ACOS) Caa-Cos. 2014, [cited August 5th, 2014]. Available from: http://www.goldcopd.org/asthma-copd-overlap.html.
  • 33. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435):709-21. doi: 10.1016/S0140-6736(04)16900-6. [PubMed: 15325838].
  • 34. Corlateanu A, Covantev S, Mathioudakis AG, Botnaru V, Siafakas N. Ashtma-Chronic obstructive pulmonary disease overlap syndrome (ACOS): Current evidence and future research directions. COPD Res Pract. 2017;3(1). doi: 10.1186/s40749-017-0025-x.
  • 35. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567-75. doi: 10.1056/NEJMoa1106955. [PubMed: 22029978]. [PubMed Central: PMC3238466].
  • 36. Gelb AF, Yamamoto A, Verbeken EK, Nadel JA. Unraveling the pathophysiology of the asthma-COPD overlap syndrome: Unsuspected mild centrilobular emphysema is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation. Chest. 2015;148(2):313-20. doi: 10.1378/chest.14-2483. [PubMed: 25950858].
  • 37. Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R, et al. Eosinophilic inflammation in COPD: Prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697-700. doi: 10.1183/09031936.00162414. [PubMed: 25323230].
  • 38. Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):758-66. doi: 10.1164/rccm.201408-1458OC. [PubMed: 25611785]. [PubMed Central: PMC4407484].
  • 39. Hardin M, Cho M, McDonald ML, Beaty T, Ramsdell J, Bhatt S, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014;44(2):341-50. doi: 10.1183/09031936.00216013. [PubMed: 24876173]. [PubMed Central: PMC4154588].
  • 40. Miravitlles M, Huerta A, Fernandez-Villar JA, Alcazar B, Villa G, Forne C, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes. 2014;12:120. doi: 10.1186/s12955-014-0120-5. [PubMed: 25189786]. [PubMed Central: PMC4173058].
  • 41. Barrecheguren M, Roman-Rodriguez M, Miravitlles M. Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD? Int J Chron Obstruct Pulmon Dis. 2015;10:1745-52. doi: 10.2147/COPD.S87025. [PubMed: 26366067]. [PubMed Central: PMC4562730].
  • 42. Golpe R, Sanjuan Lopez P, Cano Jimenez E, Castro Anon O, Perez de Llano LA. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch Bronconeumol. 2014;50(8):318-24. doi: 10.1016/j.arbres.2013.12.013. [PubMed: 24576449].
  • 43. Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127. doi: 10.1186/1465-9921-12-127. [PubMed: 21951550]. [PubMed Central: PMC3204243].
  • 44. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: Two approximations from the United States and the United Kingdom. Chest. 2003;124(2):474-81. doi: 10.1378/chest.124.2.474. [PubMed: 12907531].
  • 45. Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD overlap syndrome (ACOS): A systematic review and meta analysis. PLoS One. 2015;10(9). e0136065. doi: 10.1371/journal.pone.0136065. [PubMed: 26336076]. [PubMed Central: PMC4559416].
  • 46. Tho NV, Park HY, Nakano Y. Asthma-COPD overlap syndrome (ACOS): A diagnostic challenge. Respirology. 2016;21(3):410-8. doi: 10.1111/resp.12653. [PubMed: 26450153].
  • 47. Marsh SE, Travers J, Weatherall M, Williams MV, Aldington S, Shirtcliffe PM, et al. Proportional classifications of COPD phenotypes. Thorax. 2008;63(9):761-7. doi: 10.1136/thx.2007.089193. [PubMed: 18728201]. [PubMed Central: PMC2862964].
  • 48. Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD. 2011;8(6):400-7. doi: 10.3109/15412555.2011.611200. [PubMed: 22149399].
  • 49. Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis. 2012;7:283-9. doi: 10.2147/COPD.S30651. [PubMed: 22589579]. [PubMed Central: PMC3346210].
  • 50. Fu JJ, Gibson PG, Simpson JL, McDonald VM. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration. 2014;87(1):63-74. doi: 10.1159/000352053. [PubMed: 24029561].
  • 51. Postma DS, Reddel HK, ten Hacken NH, van den Berge M. Asthma and chronic obstructive pulmonary disease: Similarities and differences. Clin Chest Med. 2014;35(1):143-56. doi: 10.1016/j.ccm.2013.09.010. [PubMed: 24507842].
  • 52. Lee H, Tho NV, Nakano Y, Lee BJ, Park HY. A diagnostic approach and natural course of a patient with asthma-COPD overlap syndrome. Respirol Case Rep. 2015;3(4):119-21. doi: 10.1002/rcr2.130. [PubMed: 26740875]. [PubMed Central: PMC4694594].
  • 53. Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(5):1773-7. doi: 10.1164/ajrccm.162.5.9910112. [PubMed: 11069811].
  • 54. Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(8):741-50. doi: 10.1164/rccm.200904-0492OC. [PubMed: 19644045].
  • 55. Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742-50. doi: 10.1183/09031936.00129607. [PubMed: 18256071].
  • 56. Tamada T, Sugiura H, Takahashi T, Matsunaga K, Kimura K, Katsumata U, et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chron Obstruct Pulmon Dis. 2015;10:2169-76. doi: 10.2147/COPD.S88274. [PubMed: 26491283]. [PubMed Central: PMC4608617].
  • 57. Chou KT, Su KC, Huang SF, Hsiao YH, Tseng CM, Su VY, et al. Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD. Lung. 2014;192(4):499-504. doi: 10.1007/s00408-014-9591-8. [PubMed: 24816967].
  • 58. Iwamoto H, Gao J, Koskela J, Kinnula V, Kobayashi H, Laitinen T, et al. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap. Eur Respir J. 2014;43(2):421-9. doi: 10.1183/09031936.00024313. [PubMed: 23794464].
  • 59. Huang AX, Lu LW, Liu WJ, Huang M. Plasma inflammatory cytokine IL-4, IL-8, IL-10, and TNF-alpha levels correlate with pulmonary function in patients with asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome. Med Sci Monit. 2016;22:2800-8. doi: 10.12659/MSM.896458. [PubMed: 27501772]. [PubMed Central: PMC4982526].
  • 60. Araujo D, Padrao E, Morais-Almeida M, Cardoso J, Pavao F, Leite RB, et al. Asthma-chronic obstructive pulmonary disease overlap syndrome - Literature review and contributions towards a Portuguese consensus. Rev Port Pneumol (2006). 2017;23(2):90-9. doi: 10.1016/j.rppnen.2016.11.005. [PubMed: 28089081].
  • 61. Cataldo D, Corhay JL, Derom E, Louis R, Marchand E, Michils A, et al. A Belgian survey on the diagnosis of asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2017;12:601-13. doi: 10.2147/COPD.S124459. [PubMed: 28243078]. [PubMed Central: PMC5315206].
  • 62. Fu JJ, McDonald VM, Gibson PG, Simpson JL. Systemic inflammation in older adults with asthma-COPD overlap syndrome. Allergy Asthma Immunol Res. 2014;6(4):316-24. doi: 10.4168/aair.2014.6.4.316. [PubMed: 24991455]. [PubMed Central: PMC4077958].
  • 63. Harada T, Yamasaki A, Fukushima T, Hashimoto K, Takata M, Kodani M, et al. Causes of death in patients with asthma and asthma-chronic obstructive pulmonary disease overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2015;10:595-602. doi: 10.2147/COPD.S77491. [PubMed: 25834418]. [PubMed Central: PMC4370684].
  • 64. Ding B, Enstone A. Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): Structured literature review and physician insights. Expert Rev Respir Med. 2016;10(3):363-71. doi: 10.1586/17476348.2016.1144476. [PubMed: 26789845]. [PubMed Central: PMC4819878].
  • 65. Barrecheguren M, Esquinas C, Miravitlles M. The asthma-COPD overlap syndrome: A new entity? COPD Res Pract. 2015;1(1). doi: 10.1186/s40749-015-0012-z.
  • 66. Nagai AAH, Aoshiba K, Asano K, Hirata K, Ichinose M. Guidelines for the diagnosis and treatment of COPD. 3rd ed. Tokyo, Japan: The Japanese Respiratory Society. Medical Review Co. Ltd; 2010.
  • 67. Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: A randomised controlled trial. Lancet. 2000;356(9240):1480-5. doi: 10.1016/S0140-6736(00)02872-5. [PubMed: 11081531].
  • 68. Chanez P, Vignola AM, O'Shaugnessy T, Enander I, Li D, Jeffery PK, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med. 1997;155(5):1529-34. doi: 10.1164/ajrccm.155.5.9154853. [PubMed: 9154853].
  • 69. McDonald VM, Higgins I, Wood LG, Gibson PG. Multidimensional assessment and tailored interventions for COPD: Respiratory utopia or common sense? Thorax. 2013;68(7):691-4. doi: 10.1136/thoraxjnl-2012-202646. [PubMed: 23503624]. [PubMed Central: PMC3711365].
  • 70. Siva R, Green RH, Brightling CE, Shelley M, Hargadon B, McKenna S, et al. Eosinophilic airway inflammation and exacerbations of COPD: A randomised controlled trial. Eur Respir J. 2007;29(5):906-13. doi: 10.1183/09031936.00146306. [PubMed: 17301099].
  • 71. Brightling CE, Bleecker ER, Panettieri RJ, Bafadhel M, She D, Ward CK, et al. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: A randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med. 2014;2(11):891-901. doi: 10.1016/S2213-2600(14)70187-0. [PubMed: 25208464]. [PubMed Central: PMC5082845].
  • 72. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8(3):183-92. doi: 10.1038/nri2254. [PubMed: 18274560].
  • 73. Wedzicha JA, Rabe KF, Martinez FJ, Bredenbroker D, Brose M, Goehring UM, et al. Efficacy of roflumilast in the COPD frequent exacerbator phenotype. Chest. 2013;143(5):1302-11. doi: 10.1378/chest.12-1489. [PubMed: 23117188].
  • 74. Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007;175(8):783-90. doi: 10.1164/rccm.200511-1746OC. [PubMed: 17204725]. [PubMed Central: PMC1899291].
  • 75. Li H, Yang T, Ning Q, Li F, Chen T, Yao Y, et al. Cigarette smoke extract-treated mast cells promote alveolar macrophage infiltration and polarization in experimental chronic obstructive pulmonary disease. Inhal Toxicol. 2015;27(14):822-31. doi: 10.3109/08958378.2015.1116644. [PubMed: 26671198].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments